ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1119

Systematic Review of Non-surgical Therapies for Hand Osteoarthritis

Haonan Mi, Christopher Oh and Tanveer Towheed, Queen's University, Kingston, ON, Canada

Meeting: ACR Convergence 2021

Keywords: hand, Osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 8, 2021

Session Title: Osteoarthritis – Clinical Poster III (1118–1134)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: This systematic review evaluated all published randomized controlled trials (RCTs) assessing pharmacological and non-pharmacological therapies in patients with hand osteoarthritis (HOA).

Methods: The following electronic data sources were searched from inception to December 2020: MEDLINE, EMBASE, AMED, Clinicaltrials.gov and EBM reviews, including the Cochrane Database of Systematic Reviews (CDSR), Database of Abstracts of Reviews of Effectiveness (DARE), ACP Journal Club, and the Central Cochrane Database. RCTs were included if they evaluated a non-surgical, therapeutic intervention in adult subjects with HOA. The trial must have explicitly stated that a randomized method of allocation to a treatment group was used. RCTs evaluating OA at multiple sites were only included if efficacy data was presented separately for the hand. Exclusion criteria included: RCTs evaluating a surgical therapy, conference proceedings, unpublished RCTs, and non-English RCTs if their English abstracts did not contain sufficient details on trial methodology and outcomes. Study quality was evaluated using the Jadad’s scoring checklist. A meta-analysis would be completed if possible.

Results: 133 RCTs were analyzed in this systematic review. There was no consistent definition of hand OA used in the RCTs, with most trials (N = 102) not explicitly distinguishing between primary (idiopathic) and secondary OA. Sixty-one RCTs used a validated hand OA classification scheme for study entry, with the most common being the ACR classification criteria (N = 54). Radiographs were taken at baseline in seventy-seven RCTs. Most studies described their methods for randomization, blinding and allocation concealment. However, studies underreported features specific to HOA, such as pattern of joint involvement and number of affected joints. Standardized outcome assessments for pain and function were commonly presented, but measures of other HOA specific outcomes, such as health-related quality of life and patient global assessments, were underreported. The mean Jadad score for all entries was 3.08. Increasing Jadad scores were noted over time. A meta-analysis was not completed due to significant heterogeneity amongst high quality RCTs and limited quantity of data.

The following pharmacologic therapies demonstrated efficacy across multiple RCTs: systemic NSAIDs, topical NSAIDs, intramuscular and intravenous clodronate, topical capsaicin, topical trolamine salicylate, oral chondroitin sulfate. Non-pharmacologic therapies that demonstrated efficacy across multiple studies include splints, joint strengthening exercises, mobilization, paraffin baths and multidisciplinary combined intervention. The remainder of the therapies had mixed or negative results, were compared to other therapies in single studies, or efficacy compared to placebo was only demonstrated in a single study.

Conclusion: HOA is a complex area in which to study the efficacy of therapies. Future trials should consistently report on HOA specific features and outcome assessments to make clinically relevant conclusions about the efficacy of the diverse treatment options available.

Fig. 1: PRISMA diagram summarizing search strategy, study identification and retrieval.


Disclosures: H. Mi, None; C. Oh, None; T. Towheed, Abbvie, 1, 2, 6, Pfizer, 2, UCB, 1, 2, Celltrion, 1, 2, Janssen, 6, Sandoz, 1, 2, 6, Novartis, 1, 2, 6, Amgen, 1, 2, 6.

To cite this abstract in AMA style:

Mi H, Oh C, Towheed T. Systematic Review of Non-surgical Therapies for Hand Osteoarthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/systematic-review-of-non-surgical-therapies-for-hand-osteoarthritis/. Accessed January 27, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systematic-review-of-non-surgical-therapies-for-hand-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences